US Patent Issued to Goa Therapeutics on Nov. 4 for "Compositions and methods for reducing blood ethanol concentration through alcohol dehydrogenase and acetaldehyde scavengers" (Israeli Inventor)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,686, issued on Nov. 4, was assigned to Goa Therapeutics Corp. (Lewes, Del.).

"Compositions and methods for reducing blood ethanol concentration through alcohol dehydrogenase and acetaldehyde scavengers" was invented by Tami Ehrmann Barr (Metar, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions and methods for reducing blood ethanol concentration through a dual-action mechanism involving alcohol dehydrogenase (ADH) and acetaldehyde (AcH) scavengers. The present disclosure provides a formulation that accelerates ethanol (EtOH) metabolism via ADH and rapidly eliminates AcH using scavengers, thereby driv...